Introduction {#Sec1}
============

The most common type of pelvic organ prolapse (PO) is anterior-compartment prolapse. Hendrix et al. demonstrated in a group of 16,616 postmenopausal women a prevalence of anterior-compartment prolapse of 34%, and this was much higher than the rates of apical- or posterior-compartment prolapse \[[@CR1]\]. The aetiology of pelvic organ prolapse (POP) is complex and associated with various factors such as age, menopausal status and childbirth-related pelvic floor trauma \[[@CR2], [@CR3]\]. Possible surgical interventions include biological-graft, mesh and native tissue repair \[[@CR4], [@CR5]\]. The development of new surgical interventions is urgently required, and potential surgical interventions require robust evaluation. Selecting appropriate efficacy and safety outcomes is a crucial step in designing randomised trials. Outcomes collected and reported in randomised trials should be relevant to a broad range of stakeholders, including women with anterior-compartment prolapse, healthcare professionals and researchers. For example, resolution of bladder symptoms is an important outcome for all stakeholders; however, it is not commonly reported across trials. Even when outcomes have been consistently reported, secondary research methods, including pair-wise meta-analysis, may be limited by the use of different definitions and measurement instruments \[[@CR6], [@CR7]\]. A core outcome set should help address these issues. The first stage in core outcome-set development is to evaluate outcome and outcome-measure reporting across published trials. Therefore, we systematically evaluated outcome and outcome-measure reporting in published randomised trials evaluating surgical interventions for anterior-compartment prolapse. In addition, we assessed the relationships between outcome reporting quality with other important variables, including year of publication, impact factor and methodological quality.

Materials and methods {#Sec2}
=====================

This systematic review is part of a wider project of the International Collaboration for Harmonising Outcomes, Research and Standards in Urogynaecology and Women's Health (CHORUS) ([i-chorus.org](http://i-chorus.org)) and was registered with the Core Outcome Measures in Effectiveness Trials (COMET) initiative database, registration number 981, and with the International Prospective Register of Systematic Reviews (PROSPERO), registration identification CRD42017062456. We searched bibliographical databases comprising the Cochrane Central Register of Controlled Trials (CENTRAL), EMBASE and MEDLINE from inception to September 2017. The search strategy used several MeSH terms, including bladder prolapse, cystocele and POP. Randomised trials evaluating surgical interventions for anterior-compartment prolapse were eligible. We included trials evaluating the surgical management of anterior prolapse as a unicompartmental prolapse procedure, as well as trials in which anterior repair was undertaken in addition to other surgical interventions. Non-randomised studies, observational studies and case reports were excluded.

Two researchers (CD and AE) independently screened the titles and abstracts of electronically retrieved articles. The articles potentially eligible for inclusion were retrieved in full text to assess eligibility, and reference lists were independently reviewed. Any discrepancies between the researchers were resolved by review of a third senior researcher (SKD). Two researchers (CD and AE) independently extracted the study characteristics, including year of publication, journal topicality (subspecialist, general obstetrics and gynaecology or general medicine), journal's impact factor and commercial funding (yes/no). The journal's impact factor was determined using InCites Journal Citation Reports (Clarivate Analytics, Thomson Reuters, New York, NY, USA). Funding status was identified by reviewing the article text and included the donation of equipment or other resources. Two researchers (CD and AE) independently assessed the methodological quality of included randomised trials using the modified Jadad criteria (score range 1--5) \[[@CR8]\]. Studies were assessed as high quality when they achieved a score \>4. Outcome reporting quality was assessed using the Management of Otitis Media with Effusion in Cleft Palate (MOMENT) criteria (score range 1--5) \[[@CR9]\]. Studies were assessed as high quality when they achieved a score \>4.

The non-parametric Spearman's rank correlation coefficient (Spearman's rho) was used to explore univariate associations between outcome reporting quality and impact factor during the year of publication, year of publication and methodological quality. Multivariate linear regression analysis using the Enter model was also undertaken to assess the combined association of quality of outcome reporting and journal type, impact factor during the year of publication, year of publication and methodological quality (independent variables) with outcome reporting (dependent variable). All tests were two-tailed. Statistical significance was set at 0.05, and analyses were conducted using the SPSS statistical software (IBM Corp. Released 2013. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY, USA).

This study was reported with reference to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement \[[@CR6]\].

Results {#Sec3}
=======

In total, 2482 titles and abstracts were screened, and 231 potentially relevant studies were examined in detail (Fig. [1](#Fig1){ref-type="fig"}). Sixty-eight randomised trials, reporting data from 10,499 participants, met the inclusion criteria (Table [1](#Tab1){ref-type="table"}) \[[@CR5], [@CR10]--[@CR88]\]. Additionally, 12 randomised trials published long-term follow-up data \[[@CR5], [@CR22], [@CR29], [@CR39], [@CR40], [@CR64], [@CR71], [@CR72], [@CR79], [@CR81], [@CR86], [@CR87]\]Fig. 1Study search and inclusionTable 1Study characteristicsAuthorStudy yearJournalImpact factorJournal type^3^Jadad scoreMOMENT scoreStudy sizeCommercial fundingValidated questionnaire useIntervention group 1Intervention group 2Intervention group 3Intervention group 4Altman et al.^a^2011New England Journal of Medicine29.1G45389YesYesAnterior colporrhaphyTransvaginal mesh repairAntosh et al.2013Obstetrics and Gynaecology4.78S3660NoYesUse of dilators post prolapse surgeryNon-use of dilators post prolapse surgeryBallard et al.2014International Urogynecology Journal2.17G55150NoYesPreop. bowel preparationPreop. non bowel preparationBenson et al.1996American Journal of Obstetrics and Gynaecology--S3380NoNoPelvic surgery for prolapseAbdominal surgeryBorstad et al.^a^2009International Urogynecology Journal2.84SS34184NoNoAnterior colporrhaphy TVTAnterior colporrhaphy + TVT staged procedureBray et al.2017European Journal of Obstetrics & Gynaecology and Reproductive BiologyN/AG3560NoN/ASuprapubic catheterImmediate removal of catheterCarey et al.2009British Journal of Obstetrics and Gynaecology4.64S35139YesYesConventional vaginal repairMesh vaginal repairChoe et al.^a^2000Journal of Urology2.64SS2340NoYesAntilogous vaginal wall slingsMicromeshColombo et al.^a^2000British Journal of Obstetrics and Gynaecology4.64S3371NoNoAnterior colporrhaphyBurch colposuspensionda Silveira et al.2014International Urogynecology Journal2.17SS35184YesYesNative tissue repairSynthetic mesh repairDahlgren et al.2011Acta Obstetricia et Gynecologica Scandinavica2.2S33135NoYesConventional colporrhaphyPorcine skin graftDelroy et al.^a,b^2013International Urogynecology Journal2.45SS5679YesYesAnterior colporrhaphyTransvaginal mesh repairDias et al.^a,c^2016Neurourology and Urodynamics2.48SS5688NoYesAnterior colporrhaphyTransvaginal mesh repairde Tayrac et al.^a^2012International Urogynecology Journal2.53SS35147NoYesAnterior colporrhaphyTransvaginal mesh repairEk et al.^a^2012International Urogynecology Journal2.53SS2499NoYesAnterior trocar-guided transvaginal mesh repairAnterior colporrhaphy with lateral defects repairEk et al.^a^2010Neurourology and Urodynamics3.01SS5450NoN/AAnterior colporrhaphyTrocar guided transvaginal mesh repairEl-Nazer et al.^a^2012American Journal of Obstetrics and Gynaecology1.56S5544NoYesAnterior colporrhaphyTransvaginal mesh repairFarthmann et al.^a^2013International Urogynecology Journal2.45SS33200YesYesConventional anterior colporrhaphyPartially absorbable meshFeldner et al.^a,b^2010International Urogynecology Journal2.66SS5556YesYesAnterior colporrhaphySIS graftFeldner et al.^a,c^2012Clinical Science5.87G5456NoYesSmall intestine submucosa graftTraditional colporrhaphyGalvind et al.2007Acta Obstetricia et Gynecologica Scandinavica1.94G32136NoN/A3-h catheterisation and vaginal tampon24-h catheterisation and vaginal tamponGandhi et al.^a^2005American Journal of Obstetrics and Gynaecology4S35154NoNoAnterior colporrhaphyColporrhaphy and fascial patchGeller et al.2011British Journal of Obstetrics and Gynaecology4.34S3450NoN/ASpontaneous postop. micturitionMicturition after bladder refillGlazener et al.^b^2017The LancetN/AG361352NoYesStandard repairMesh repairBiological graftGlazener et al.^c^2017Health Technology AssessmentN/AG463087NoYesStandard repairMesh repairBiological graftGuerette et al.^a^2009Obstetrics and Gynaecology4.69S4494YesYesAnterior repairAnterior repair + porcine graft meshGupta et al.^a^2014South African Journal of Obstetrics & Gynaecology0.23S34106NoN/AAnterior repairAnterior repair + meshHakvoort2004British Journal of Obstetrics and Gynaecology4.75S23100NoN/A4-day catheterisation1-day catheterisationHenn et al.2016International Urogynecology Journal1.83SS5680NoN/AVaginal vasoconstrictor infiltrationVaginal saline infiltrationHiltunen et al.^a,b^2007Obstetrics and Gynaecology4.45G34202NoNoAnterior colporrhaphyTransvaginal mesh repairNieminen et al.^a,c^2010American Journal of Obstetrics and Gynaecology4.98G34202NoNoAnterior colporrhaphyTransvaginal mesh repairNieminen et al.^a,c^2008International Urogynecology Journal2.51SS32202NoNoAnterior colporrhaphyTransvaginal mesh repairHuang et al.2010International Urogynecology Journal2.66SS3390NoN/ARemoval of catheter on day 2 postop.Removal of catheter on day 3 postop.Removal of catheter on day 4 postop.Hviid et al.^a^2010International Urogynecology Journal2.66SS3361NoYesConventional anterior repairAnterior repair + porcine skin collagen implantsIglesia et al.2010Obstetrics and Gynaecology4.98S5665NoYesConventional colporrhaphy or uterosacral ligament suspensionVaginal colpopexy with meshKamilya et al.2010Journal of Obstetrics and Gynaecology Research1.13S36200NoN/ACatheter removal day 4 postop.Catheter removal day 1 postop.Khalil et al.2016Journal of Clinical Anaesthesia1.64S5557NoNoGeneral anaesthesiaGeneral anaesthesia + pudendal nerve blockKringel et al.^a^2010International Urogynecology Journal2.66SS35232NoN/AIntraurethral catheterisation 24 hIntraurethral catheterisation 96 hSuprapubic catheterisation 96 hLambin et al.^a^2013International Urogynecology Journal2.45SS3568NoYesAnterior colporrhaphy with vaginal colposuspensionTransvaginal mesh repairLazzeri et al.^a^2007Journal of Urology4.27S3547NoYesAbdominal prolapse repair NO Burch colposuspensionAbdominal prolapse repair and Burch colposuspensionLindholm et al.1985International Journal of Gynaecology and ObstetricsN/AS4320NoN/APhenoxybenzamine useControlMahuvrata et al.2011Journal of Obstetrics and Gynaecology0.75G5566NoYesMesh repairNo meshPDSVicrylMcNanley et al.2012Female Pelvic Medicine & Reconstructive Surgery0.42SS3660NoYesDocusate sodium laxative postoperativeOther laxatives postoperativeMenefee et al.^a^2011Obstetrics and Gynaecology5.34S5699YesYesAnterior colporrhaphyMesh repairBiological graftMeschia et al.^a^2003American Journal of Obstetrics and Gynaecology2.96S3550NoNoEndopelvic fascia plicationTVT + Anterior repairMinassian et al.^a^2014Neurourology and Urodynamics2.71SS3570NoYesConventional anterior colporrhaphyAbdominal paravaginal defect repairMiranda et al.^a^2011Journal of obstetrics and gynaecology Canada1.42S5222NoN/AAnterior colporrhaphy with polyglactin 910 meshAnterior colporrhaphy without plication of pubovesical fasciaNatale et al.^a^2009International Urogynecology Journal2.84SS35190NoYesAnterior colporrhaphySynthetic meshPark et al.^a^2013International Urogynecology Journal2.45SS3592NoYesAnterior repair + TVTTVTPauls et al.2015American Journal of Obstetrics and Gynaecology5.23S5574NoYesDexamethasone prior to surgeryPlaceboPloege et al.2015International Urogynecology Journal1.83SS3691YesYesProlapse surgeryProlapse surgery + TVTQatawneh et al.2013Gynaecological Surgery0.46S35116NoNoNative tissue repairMesh repairQuadri et al.^a^2000International Urogynecology Journal1.15SS3345NoN/AUse of PGE-2ControlRobert et al.^a^2014Obstetrics and Gynaecology4.76S5457YesYesAnterior colporrhaphyTransvaginal mesh repairRudnicki et al.^a,b^2013British Journal of Obstetrics and Gynaecology2.9G35160NoYesAnterior colporrhaphyTransvaginal mesh repairRudnicki et al.^a,c^2015British Journal of Obstetrics and Gynaecology2.9G33138NoYesAnterior colporrhaphyTransvaginal mesh repairSand et al.2001American Journal of Obstetrics and Gynaecology2.72S34161NoN/AConventional anterior colporrhaphyUse of meshSchierlitz et al.2013International Urogynecology Journal2.45SS3580NoYesConventional pelvic repairConventional pelvic repair + TVTSegal et al.2006International Urogynecology Journal2.38SS3540NoNoLocal anaesthesiaGeneral anaesthesiaSivaslioglu et al.^a^2007International Urogynecology Journal2.79SS3290NoYesAnterior colporrhaphyTransvaginal mesh repairStekkinger et al.2011Gynecologic and Obstetric investigation1.74G35126NoN/ATrans urethral catheterS/pubic catheterTamanini et al.^a,b^2012International Braz J Urol: official journal of the Brazilian Society of Urology1.24G45100NoYesAnterior colporrhaphyTransvaginal mesh repairTamanini et al.^a,c^2012International Braz J Urol: official journal of the Brazilian Society of Urology1.24G45100NoYesAnterior colporrhaphyTransvaginal mesh repairTamanini et al.^a,c^2014Journal of Urology4.68S4592NoYesAnterior colporrhaphyTransvaginal mesh repairTantanasis et al.^a^2008Acta Obstetricia et Gynecologica Scandinavica1.72S2250NoNoAnterior colporrhaphyBladder base tape repairThiagamoorthy et al.2013International Urogynecology Journal2.45SS56190NoN/AUse of postop. vaginal packNo use of postop. vaginal packTincello et al.^a^2009British Journal of Obstetrics and Gynaecology4.18S3431NoYesColposuspension + anterior repairTVT + Anterior repairTurgal et al.^a^2013European Journal of Obstetrics & Gynaecology and Reproductive Biology2.4G3240NoNoAnterior colporrhaphyTransvaginal mesh repairVan et al.2011International Urogynecology Journal2.39SS35179NoN/A1-day suprapubic catheterisation3-day suprapubic catheterisationVollebregt et al.^a,b^2011British Journal of Obstetrics and Gynaecology2.96S56125NoYesAnterior colporrhaphyTransvaginal mesh repairVollebregt et al.^a,c^2012Journal of Sexual Medicine3.67SS56125NoYesAnterior colporrhaphyTransvaginal anterior or posterior mesh repairWeber et al.^a,b^2001American Journal of Obstetrics and Gynaecology2.72G23114NoNoUnilateral anterior colporrhaphyAnterior colporrhaphyTransvaginal mesh repairChmielewski et al.^a,c^2011American Journal of Obstetrics and Gynaecology5.34G44114NoNoUnilateral anterior colporrhaphyAnterior colporrhaphyTransvaginal mesh repairWeemhoff et al.^a^2011International Urogynecology Journal2.39SS36246NoN/APostop. catheterisation for 2 daysPostop. catheterisation for 5 daysWei et al.^a^2012New England Journal of Medicine29.36G56337NoYesAnterior repairTVT + Anterior repairWestermann et al.2016Female Pelvic Medicine & Reconstructive Surgery1.49SS4593NoYesUse of postop. vaginal packNo use of postop. vaginal packWithagen et al.^b^2011Obstetrics and Gynaecology5.34S56194NoYesConventional colporrhaphyTransvaginal mesh repairWithagen et al.^c^2011British Journal of Obstetrics and Gynaecology4.34S5659NoYesConventional colporrhaphyTransvaginal mesh repairMilani et al.^c^2011Journal of Sexual Medicine3.67SS3659NoYesConventional colporrhaphyTrocar-guided MeshYuk et al.^a^2012Journal of Minimally Invasive Gynaecology2.1S3387NoN/A2-point mesh4-point mesh*SS* subspecialty (urogynaecology),*S* specialty (obs/gyn),*G* general,*TVT* tension free vaginal tape (retropubic tape), *PDS* polydioxanone^a^Studies focused on surgical management of anterior repair solely, ^b^original study, ^c^secondary analysis.

Trials were published between 1985 and 2017, with most being published in subspecialty journals (33/80; 41%). Trials were frequently published in journals with an impact factor \<3 \[median = 2.7; interquartile range (IQR) = 2.2--4.3\] and were generally small (median = 93; IQR = 60--154). Ten trials (14%) declared commercial funding. The methodological quality and outcome reporting quality varied considerably between trials (Table [1](#Tab1){ref-type="table"}). One hundred different outcomes were organised into 11 thematic domains. The three most commonly reported thematic domains were presence of symptoms posttreatment (50 trials, 28 outcomes; 28 outcome measures), prolapse treatment success rates (47 trials; 3 outcomes; 16 outcome measures) and perioperative complications (46 trials; 15 outcomes; 13 outcome measures) (Table [2](#Tab2){ref-type="table"}). Commonly reported outcomes were anatomical prolapse stage (43 trials; 54%), commonly assessed using the Pelvic Organ Prolapse Quantification (POP-Q) instrument (35 trials; 81%), QoL (25 trials; 31%); and intra- and postoperative complications (23 trials; 29%). Patient-reported outcomes were infrequently reported; for example, a minority of trials reported prolapse symptoms (9 trials; 11%), urinary symptoms (11 trials; 14%) and sexual dysfunction (14 trials; 17%) (Table [3](#Tab3){ref-type="table"}). Eleven trials (14%) reported patient satisfaction.Table 2Most commonly reported outcome domainsOutcome domainsRCTs reporting on the domainOutcomes reportedOutcome measures reportedPresence of symptoms posttreatment502828Prolapse treatment success rate47316Perioperative complications and observations461513Quality of life and satisfaction with treatment40525Treatment success evaluation1511--Postoperative catheterisation101710Pain947Mesh-related outcomes83--*RCT* randomised controlled trialTable 3Outcomes reported in 80 randomised controlled trials (RCTs) evaluating surgical management of anterior-compartment prolapseOutcomesReporting studiesProlapse treatment success rateAnatomical prolapse stage43Composite anatomical/functional success rate3Urethral mobility1Perioperative complications and observationsComplications intra-/postoperatively23Postoperative hospital stay length11Blood loss intraoperatively6Duration of operation6Quality and time of recovery4Postoperative nausea and vomiting3Bleeding postoperatively (with/out vaginal pack use)2Constipation preoperatively2Blood pressure2Blood transfusion indicated2Heart rate change2Consistency of bowel movement postoperatively1Intra- and postoperative morbidity1Time to first postoperative bowel movement1Time to mobilisation1PainPostoperative pain8Intraoperative requirement of analgesics1Total analgesic consumption1Pain level associated with first postoperative bowel movement1Postoperative catheterisationPostoperative UTI5Recatheterisation rates5Postoperative catheterisation duration4First postvoid residual volume4Time to normal spontaneous voiding2Acute urinary retention1Bacterial count in the urine1Catheter blockage1Day of spontaneous voiding1Diagnostic accuracy of different voiding trial methods1Mean residual urine volume pre- and postoperatively1Prediction of voiding dysfunction lasting \>7 days.1Prolonged catheterisation1Pyelectasia1Residual urine volume1Urinary retention prevention with intravesically administered prostaglandin-E21Urinary retention rates1Postoperative vaginal packingBleeding postoperatively (with/out vaginal pack use) (compared with menstrual average)1Bleeding postoperatively (with/out vaginal pack use)1Presence of vaginal haematoma1Presence of vaginal infection1Bother related to the pack1Presence of symptoms posttreatmentSexual dysfunction symptoms14Urinary symptoms11Prolapse symptoms postoperatively9Dyspareunia6SUI postoperatively5De novo SUI postoperatively4Change in urinary symptoms (any)3Prolapse symptoms severity3De novo urinary urgency2Postoperative urinary symptoms2Urinary symptoms severity2Bowel symptoms2Faecal incontinence2Postoperative bowel symptoms2Change in incontinence rates1De novo urinary symptoms1De novo voiding difficulty1Urgency and urge urinary incontinence1Worsening urinary symptoms (any)1Obstructed defecation1Back pain improvement1Change in a pelvic symptom score1Change of vaginal symptoms1Symptomatic prolapse improvement1Time of prolapse recurrence1De novo dyspareunia1Sexual function in partner1QoL and satisfaction with treatmentQoL and impact from symptoms evaluation25Patient satisfaction with treatment11Surgeon satisfaction with operation2Patient acceptability of preoperative bowel preparation1Surgeon---ease of procedure1Treatment success evaluationSymptoms---presence posttreatment5Subjective cure rates3Cure of SUI postoperatively3Reoperation rates3Symptoms---bother change2Retreatment success rates1Symptom improvement1Functional recurrence1Healing abnormalities1Need for subsequent anti-incontinence surgery1Treatment of overactive bladder1Mesh-related outcomesMesh erosion6Mesh shrinkage2Degree of morbidity in mesh vs. native tissue1Cost/effectivenessCost-effectiveness of treatment2Cost of procedure1Recruitment feasibilityNumber of patients agreed to participate1Number of eligible patients1Physician acceptance and protocol1Rate of recruitment compliance1*UTI* urinary tract infection,*SUI* stress urinary incontinence, *QoL* quality of life

Forty-two randomised trials compared native tissue or biological graft versus mesh repair for anterior vaginal prolapse. Mesh-related complications were rarely reported: seven trials (9%) reported mesh erosion, six (7%) reported mesh shrinkage and a single trial (1%) reported the degree of morbidity associated with mess Only three trials (4%) evaluated cost effectiveness. One hundred and twelve different outcome measures wer reported (Table [4](#Tab4){ref-type="table"}). Forty-six questionnaires were used as measurement instruments, most of which were validated (45; 98%). Anterior prolapse symptoms were measured using the Pelvic Organ Prolapse Urinary Incontinence Sexual Questionnaire (PISQ-12) (13 trials; 16%), Urogenital Distress Inventory (UDI-6) (11 trials; 14%) and the Pelvic Floor Distress Inventory (PFDI-20) (9 trials; 11%). QoL was measured using the Prolapse Quality of Life (P-QoL) (10 trials; 12%), Pelvic Floor Impact Questionnaire Short Form (PFIQ-7) (8 trials; 10%) and the Incontinence Impact Questionnaire Short Form (IIQ-7) (6 trials; 7%). Table [5](#Tab5){ref-type="table"} summarises our main findings, demonstrating the most frequently reported outcomes. It reveals the significant discrepancies in terms of outcome reporting.Table 4Outcome measures reported in 80 randomised controlled trials (RCTs) evaluating surgical management of anterior-compartment prolapseOutcomesNo of reporting studiesProlapse treatment success rateAnatomical success rate POP-Q \< 223Anatomical success rate (POP-Q ≤ 1)5Anatomical success rate (postoperative POP-Q stage improvement)5Anatomical success rate (POP above hymen)3Anatomical success rate POP-Q ≤ 22Anatomical success rate (POP-Q \< 2 vs. POP-Q ≤ 1)1Anatomical success rate POP-Q Index (POP-Q-I) = 01Anatomical success rate (postoperative POP-Q + BW stage improvement)1Anatomical success rate (cotton swab mobility test)1Composite success rate (POP-Q \< 2 + UDI question 16 negative1Composite success rate (POP above hymen + VAS \>20 (0--100 scale))1Composite success rate - (POP above hymen + no symptoms)1Composite success rate - (apex below levator plate + no symptoms)1Denovo POP in untreated compartments (POP-Q ≥ 2)1Denovo POP in untreated compartments (POP ≥ hymen)1Recurrence rate of POP (halfway BW stage change)1Perioperative complications and observationsPostoperative hospital stay length (days)11Blood loss (ml)8Duration of operation (min)6PONV (postoperative nausea and vomiting), visual analogue scale \[VAS (0--10)\]2PONV scale2PONV QoR (quality of recovery) score \> 502Recovery time (days)2PONV intensity score \[QoR (0--40)\]1Blood pressure (mmHg)1Heart rate (beats/min)1Consistency of bowel movement (Bristol stool scale)1Constipation perioperatively (Rome III constipation questionnaire)1Time to mobilisation (days)1PainVAS (0--10)5VAS (0--100)2VAS (not specified)2Mcgill pain questionnaire2Verbal numerical pain scale (0--10)1Baudelocque's questionnaire1Nonvalidated questionnaire (0--3)1Postoperative catheterisationPostoperative catheterisation duration (days)4Day of spontaneous voiding (days)3Bacterial count in the urine1Residual urine volume (ml)1First PVR (postvoid residual volume) \> 150 ml1First PVR \> 1500 ml1Mean residual urine volume pre- and postoperatively (ml)1Recatheterisation if PVR \>200 ml1Prediction of voiding dysfunction \>7 days (positive predictive value)1Diagnostic accuracy of two voiding trial methods (sensitivity/specificity)1Postoperative vaginal packingBleeding postoperatively (with/out vaginal pack use) (compared with menstrual average)1Bleeding postoperatively (with/out vaginal pack use) \[FBC change and volume (ml)\]1Blood pressure (mmHg)1Heart rate (beats/min)1Blood transfusion indicated (yes/no)1Vaginal haematoma (TVUSS)1Vaginal infection (HVS)1Bother related to the pack (VAS 0--100)1Presence of symptoms posttreatmentPISQ-12 (Pelvic Organ Prolapse Urinary Incontinence--Sexual Questionnaire)13UDI-6 (Urogenital Distress Inventory)11PFDI-20 (Pelvic Floor Distress Inventory)9SUI urodynamic studies7DDI (Defecatory Distress Inventory)5ICIQ-UI SF (International Consultation on Incontinence Questionnaire--Short Form)4SUI cough test (presence of leakage)4FSFI (Female Sexual Function Index)2ICIQ-BS (International Consultation on Incontinence Questionnaire--Bowel Symptoms)2PGI-I (Patient Global Impression of Improvement)2OAB-V8 (Overactive Bladder-Validated 8-question)2POPDI-6 (Pelvic Organ Prolapse Distress Inventory)2POP-SS (Pelvic Organ Prolapse Severity of Symptoms)2UDI-I (Urogenital Distress Inventory--Irritative)2UDI-O (Urogenital Distress Inventory-Obstructive)2UDI-S (Urogenital Distress Inventory--Stress)2AUASS \[American Urological Association Symptom Score (urinary)\]1CRADI-8 (Colorectal--Anal Distress Inventory)1CRAIQ-7 (Colorectal--Anal Impact Questionnaire)1Danish prolapse questionnaire1ICIQ-VS (International Consultation on Incontinence Questionnaire--Vaginal Symptoms)1MESAAQ (Medical Epidemiologic and Social Aspects of Ageing Questionnaire)1MHU (French Urinary Dysfunction Measurement Scale)1MSHQ (Male Sexual Health Questionnaire)1PGI-S (Patient Global Impression of Severity)1QS-F (Sexual Quotient--Female Version)1SUI number of daily pads1Impact on quality of lifeP-QoL (Prolapse Quality of Life)10PFIQ-7 (Pelvic Floor Impact Questionnaire--Short Form)8IIQ-7 (Incontinence Impact Questionnaire--Short Form)6ICIQ-UI SF (International Consultation on Incontinence Questionnaire--Urinary Symptoms)4ICIQ-VS (International Consultation on Incontinence Questionnaire--Vaginal Symptoms)3KHQ (King's Health Questionnaire)3UIQ-7 (Urogenital Impact Questionnaire)3DDI (Defecatory Distress Inventory)2EQ5D \[Quality of Life (EuroQol)\]2POPIQ-7 (Pelvic Floor Impact Questionnaire--Prolapse)2VAS (0--10)2CRAIQ-7 (Colorectal--Anal Impact Questionnaire)1PSI-QOL (Prolapse Symptom Inventory and Quality of Life Questionnaire)1SF-12 (12-Item Short-Form Health Survey)1SF-36 (36-Item Short-Form Health Survey)1SatisfactionPatient satisfaction with treatment, VAS (0--10)3Patient satisfaction with treatment, PGI (Patient Global Improvement)3Patient satisfaction with treatment (yes/no)3Patient satisfaction with treatment, VAS (0--100)2Patient satisfaction with treatment, VAS (0--4)1Patient satisfaction with treatment, custom (0--5)1Patient acceptability of preoperative bowel preparation, VAS) (0--4)1Surgeon satisfaction with preoperative bowel preparation, Likert scale (0--4)1Surgeon ease to perform operation, Likert scale (0--4)1Surgeon's satisfaction with operation, VAS (0--100)1Cost/effectivenessIncremental cost per quality-adjusted life-year (QALY)2Cost of procedure (US\$)1*TVUSS* transvaginal ultrasound scan, *HVS* high vaginal swab, *FBC* full blood countTable 5Reported outcomes by by more than eight studies with greater than 93 participants (median value)StudySample size (*N*)OutcomesAnatomical prolapse stageQuality of life and impact from symptomsComplications intra-/postoperativelySexual dysfunction symptomsPostoperative hospital stay lengthUrinary symptomsPatient satisfaction with treatmentProlapse symptoms postoperativelyPostoperative painGlazener et al.1352xxxxxxAltman et al.389xxxWei et al.337xxWeemhoff et al.246xNieminen et al.203xxHiltunen et al.202xxFarthmann et al.200xxxKamilya et al.200xWithagen et al.194xxxxxNatale et al.190xxThiagamoorthy et al.190xda Silveira et al.184xxBorstad et al.184xVan et al.179xSand et al.161xRudnicki et al.160xxxGandhi et al.154xBallard et al.150xde Tayrac et al.147xxxCarey et al.139xxxxRudnicki et al.138xDahlgren et al.135xxxxStekkinger et al.126xVollebregt et al.125xxxxQatawneh et al.116xxxxWeber et al.114xxChmielewski et al.114xGupta et al.106xxTamanini et al.100xxxxHakvoort100xMenefee et al.99xxxxEk et al.99xGuerette et al.94xxxxWestermann et al.93xxStudies not included\<93191611558434Total studies4325231411111198

We observed a moderate correlation between outcome reporting quality and year of publication in the univariate analysis (*r* 0.458; *p*  \< .001) and study quality (*r* 0.409; *p*  \< .001) (Table [6](#Tab6){ref-type="table"}). The latter index significantly affected outcome reporting in the multivariate logistic regression (β = 0.412; *p*  = .018).Table 6Univariate and multivariate correlation with outcome reporting qualityFactorUnivariateMultivariateSpearman's rho*P* valueBeta*P* valueStudy quality (Jadad)00.409**\<0.001**0.412**0.018**Journal IF0.0530.6430.0780.306Year of publication0.458**\<0.001**0.1490.295Study size0.2150.0510.0080.961Journal type----0.0240.852Commercial funding----−0.0130.918Validated questionnaire----1.3100.196Bolded data statistically significant

Discussion {#Sec4}
==========

Summary of main findings {#Sec5}
------------------------

This study demonstrated considerable variation in outcome and outcome-measure reporting across published trials evaluating surgical interventions for anterior-compartment prolapse. Commonly reported outcomes included normalised anatomy, QoL and pain. Patient-reported outcomes were infrequently reported, and a minority of trials reported on patient satisfaction. Mesh-related complications, including erosion, shrinkage and morbidity, were rarely reported. Forty-five different questionnaires were used as measurement instruments; most were validated. Only a few trials considered cost effectiveness.

Strengths and limitations {#Sec6}
-------------------------

Strengths of our systematic review include originality, a rigorous search strategy and methodological robustness. To our knowledge, this systematic review is the first to evaluate outcomes and outcome measures in anterior-compartment prolapse trials. Study screening and selection and data extraction and assessment were conducted independently by two researchers to avoid bias. Our findings were based on outcome reporting in published randomised trials. The exclusion of observational studies may have potentially missed outcomes related to harm \[[@CR89], [@CR90]\] and selecting only trials reported in English may have introduced selection bias. The variation of interventions for correcting anterior prolapse may have caused variation in outcome and outcome-measure reporting.

Interpretation {#Sec7}
--------------

Randomised trials require a substantial investment of resources. Variation in outcomes and outcome measures limits the ability of trials to be combined with meta-analyses, which contributes to inevitable research waste, as identified in various areas of women's health, including childbirth trauma, endometriosis and pre-eclampsia \[[@CR91]--[@CR94]\]. This systematic review is the first step in the development of a minimum data set, which will be known as a core outcome set. It will be developed with reference to methods described by the COMET initiative, Core Outcomes in Women's and Newborn Health (CROWN) initiative and other core-outcome-set development studies, including those on endometriosis, pre-eclampsia, termination of pregnancy, Twin-Twin Transfusion Syndrome and neonatal medicine \[[@CR95]--[@CR99]\].

CHORUS is aiming to work towards a standardisation of outcomes and outcome measures and subsequently establish a minimum of standards in research and clinical practice. Chorus working groups are currently evaluating reported outcomes in all areas of urogyneacology and have been registered with the COMET (registration number 981, <http://www.comet-initiative.org/studies/details/981>) and CROWN initiatives. Each working group has carefully considered the scope of its work \[[@CR100]\], and CHORUS will replicate the success of other international initiatives that have standardised outcome selection, collection and reporting across preterm birth research \[[@CR101]\].

In the absence of a core outcome, we recommend QoL (incorporating sexual function), postoperative complications, patient and physician satisfaction and postoperative prolapse, bladder and bowel symptoms be collected across all anterior prolapse trials.

Conclusion {#Sec8}
==========

Anterior-compartment prolapse trials report many different outcomes and outcome measures and often neglect to report important safety outcomes. Developing, disseminating and implementing a core outcome set will help address these issues.

Conflicts of interest {#FPar1}
=====================

The authors report that they have no conflicts of interest.
